Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination - Wikidata - awgldk - TriplyDB

Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination

Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination

http://www.wikidata.org/entity/Q35012887

about

Radiotherapy combination opportunities leveraging immunity for the next oncology practice The Concept of Hormesis in Cancer Therapy - Is Less More?Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy T-cell receptor gene therapy--ready to go viral?Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells Effect of intravenous immunoglobulin on the function of Treg cells derived from immunosuppressed mice with Pseudomonas aeruginosa pneumonia.Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs.Chemoimmunotherapy.Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response Chronic chemoimmunotherapy achieves cure of spontaneous murine mammary tumors via persistent blockade of posttherapy counter-regulation Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastoma IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer.Whole recombinant yeast vaccine induces antitumor immunity and improves survival in a genetically engineered mouse model of melanoma.Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model Effective chemoimmunotherapy with anti-TGFβ antibody and cyclophosphamide in a mouse model of breast cancer.Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy.Therapeutic cancer vaccines in combination with conventional therapy.Cancer immunotherapy and nanomedicine.Contribution of the immune system to the chemotherapeutic response.Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects.Immunotherapy: a useful strategy to help combat multidrug resistance.Chemoimmunotherapy: reengineering tumor immunity.Targeting Tregs in Malignant Brain Cancer: Overcoming IDO.Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer.Exploiting dendritic cells in the development of cancer vaccines.Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.Clinical overview of metronomic chemotherapy in breast cancer.Dendritic cell-based immunotherapy: a basic review and recent advances.Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome.Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical Trial.Low-dose cyclophosphamide induces anti-tumor T-cell responses which associate with survival in metastatic colorectal cancer.

P2860

Q26738443-655FE487-8D5A-403D-8AD7-85A771ACE431 Q26800519-8B22C76D-0F00-4150-8FEB-DC432372E10E Q27027093-43C4F5A2-3FBA-4EE2-9B64-A57CD85638F3 Q28081611-6EA0589F-BA69-44A3-8114-EFB1EF1CCEB5 Q28732041-8868A79D-9A15-4806-8D25-25324CCD3C5E Q33648112-255F396F-32DE-4FA2-85E3-07A04629E946 Q33653210-D43BF1A0-11CA-4A85-B919-589800F8B786 Q33896713-DD4F90C0-8A2B-4208-B0F9-9B028881E613 Q34058792-3C00C1B2-7512-4343-813A-D678FC4B268A Q34173568-A93B1791-BD64-4EDD-B465-B929C7F833C7 Q34187201-947E4569-9B6E-467B-92A1-A97CCC6DB5A9 Q34644359-1BDA97B5-E3AD-4C76-8F7B-9028BFF4CCC2 Q34732294-64B35D89-F361-4DC0-8BEC-177A007D6109 Q34759603-607C78BA-E19E-4BEB-940C-69FC48F37325 Q35058213-F90D60E3-C0BD-4775-A589-447FC50E2C9B Q35201890-8E33B489-3747-4750-9A4B-F93C628EA543 Q35269390-A9CFB0D9-0CE7-46E8-8EF2-180610742D36 Q35674805-5B122A9B-F255-4443-952B-2AB26521D3B4 Q35747826-DA56C337-6F3C-4D29-9FBB-205A07368DC9 Q35886767-61825744-5887-4B5A-B23F-998207AF7915 Q36130491-595E99F0-7185-4F36-9DC0-1E77B2138C2D Q36193004-DAA718E5-25F7-4708-BE55-FB9E9B3B7435 Q36600960-44A75BF0-DE41-478D-B373-19EE0EEC4EAB Q37459043-AACFD979-B102-4C28-A98B-40037D3AAEC9 Q37520816-E157B721-C131-4D18-A0D7-726DAA52A748 Q37771267-E56E96FF-621A-4273-966C-6EED12CE0EDE Q37785836-FAACFD71-D002-44BA-BFD1-BB8291A38BFA Q37832967-1042FC77-5EF0-4997-B820-30C5D1C98F4C Q37991701-F44D443D-B2CC-4E3B-8580-130FE33F0A2B Q38000768-4830E174-8EDC-472E-95D7-C2F12CB2CD37 Q38079749-4397BCCF-5CF4-4E4F-A002-60139A0697C8 Q38110540-D407BA83-AFE2-42CF-BC4B-998FBD292B96 Q38115968-0BE9AFAA-9DA0-4E89-B200-0F0B8D5672AD Q38148774-DE529176-A515-4E72-89B7-16BE0CA2A426 Q38185156-D9973EBB-A25F-4FF6-BFC3-9783A0BA66E0 Q38560651-4C481262-7AE6-4F2B-9C8B-42255E63C11E Q38665350-29E754BE-2B11-4385-BC97-271B0A695333 Q39474140-D3910384-CC3D-4AAF-B035-6AD78703D182 Q40062688-8448F337-A502-4844-85D5-B68FAF2FB8DA Q40074035-0BFF775B-FAAF-4A6E-BE63-3056253EB32D

P2860

Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination

http://www.wikidata.org/entity/Q35012887

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Cyclophosphamide resets dendri ...... regulatory T cell elimination

@ast

Cyclophosphamide resets dendri ...... regulatory T cell elimination

@en

type

label

Cyclophosphamide resets dendri ...... regulatory T cell elimination

@ast

Cyclophosphamide resets dendri ...... regulatory T cell elimination

@en

prefLabel

Cyclophosphamide resets dendri ...... regulatory T cell elimination

@ast

Cyclophosphamide resets dendri ...... regulatory T cell elimination

@en

P1433

Q35012887-DA1183F2-4B05-4EBD-B936-F071177033FE

P1476

Q35012887-AD687CF8-9BC5-45B2-A939-9A028CFDF9B7

P2093

Q35012887-1D9C6223-0481-471C-B6B6-61E7306A82E1

Q35012887-45C74BB3-7323-4312-8450-9F89EC67C190

Q35012887-5789A6EF-3807-4429-8157-E18D8C51E7E5

Q35012887-5DAEC19E-87E8-4666-AE7C-5F43B8FEFE72

Q35012887-9A905935-2B75-42BF-8923-CCCDCABFA347

Q35012887-DE575653-A691-464E-ABC1-A9747E722DD2

P2860

Q35012887-1BD1AE78-DF41-4190-95A2-966F7A74C41B

Q35012887-2965B432-DCEA-4979-88EB-D14C27C169DE

Q35012887-2CB9B94A-AC2F-4B7F-BF60-AA8EC6B11DAA

Q35012887-310AC76C-8F9C-4551-8AC4-459CF7F3DC20

Q35012887-3446569E-80BF-44B9-85B3-9776F5534BC5

Q35012887-361FE224-A4F9-4038-8767-566B98ACA701

Q35012887-3893F7B1-50D1-4FC9-838D-AD819A65E3C2

Q35012887-3C6EECA7-E996-4840-8865-6030C353835E

Q35012887-3F93D653-63C4-4776-B65A-F3C4FE96C39B

Q35012887-40E2EC4E-131B-48D6-8869-B786A05307A0

P2888

Q35012887-D10C9AE5-67BF-419D-B646-31945C254FB2

P304

Q35012887-44BAF60A-FC57-4E10-B291-2994FD570F08

P31

Q35012887-A9FBE713-107E-4CFC-8917-75434F334741

P356

Q35012887-46300F06-EEE2-4865-A3E4-433715E8B7A9

P433

Q35012887-A8B2FCE6-0BBF-44BF-9B09-26E409A0C1BF

P478

Q35012887-D903B976-D6FA-448E-976F-C0EDF5CF6F92

P50

Q35012887-5B8CD5AF-CA6D-464A-BAA5-88E44DE843ED

P577

Q35012887-C76F589E-E07D-4745-B192-AACB003C0922

P5875

Q35012887-9E5A6519-331B-4382-B8A1-AEB7AE50CB78

P698

Q35012887-4344C35E-AA4C-457E-B0A6-46DF575D91BB

P932

Q35012887-506A187D-851C-43C9-AE95-826859E9FA99

P356

S00262-009-0734-3

P1433

Cancer Immunology, Immunotherapy

P1476

Cyclophosphamide resets dendri ...... regulatory T cell elimination

@en

P2093

Karl B Bezak

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Yoshimura

http://www.w3.org/2001/XMLSchema#string

Leo Luznik

http://www.w3.org/2001/XMLSchema#string

Maria A Pletneva

http://www.w3.org/2001/XMLSchema#string

Richard D Schulick

http://www.w3.org/2001/XMLSchema#string

Vedran Radojcic

http://www.w3.org/2001/XMLSchema#string

P2860

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

T cell homeostatic proliferation elicits effective antitumor autoimmunity

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction

Calreticulin exposure dictates the immunogenicity of cancer cell death

Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice

The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

In vivo analysis of dendritic cell development and homeostasis

Chemokine and chemokine receptor expression by liver-derived dendritic cells: MIP-1alpha production is induced by bacterial lipopolysaccharide and interaction with allogeneic T cells.

P2888

s00262-009-0734-3

P304

137-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-009-0734-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26659863

http://www.w3.org/2001/XMLSchema#string

P698

19590872

http://www.w3.org/2001/XMLSchema#string

P932

3103867

http://www.w3.org/2001/XMLSchema#string